ORBIS Compliance

Chile Mandatory Labeling: Increased road safety when using medications

Published /Effective /Chile

The document reports that Chile is implementing mandatory labeling on certain medications for the first time to warn the public about potential negative effects on driving and operating machinery.

The new label consists of a pictogram visible on the packaging, depicting a car inside a red triangle. Pharmaceutical companies will be required to include this label on products whose active ingredients may decrease concentration, cause drowsiness, or impair reflexes or coordination.

It is emphasized that the purpose of the label is to warn and educate, not to prohibit use or impede driving, but rather to alert the public to potential risks and encourage medical consultation when necessary.

WHOM DOES IT IMPACT?

The direct impact is felt by healthcare professionals, the pharmaceutical industry and distribution chains, users, and end consumers.

CONCLUSION:

This measure is a significant advance in public health and road safety because it transforms a previously vague warning into a clear and universal message, helping more people make informed decisions before driving under potentially risky influences.

Regulatory Authority

ISP

Regulatory Impact

Impact TypeStatus
Top Priority
Type Certificate
Spectrum Bands
Import Changes (HS Codes)
Standard Changes
Product Changes
Label Changes

Chile Quick Facts

Regulatory AgencySubsecretaría de Telecomunicaciones (SUBTEL)
Certification TypeMandatory
License ValidityIndefinite
Application LanguageSpanish
Legal License HolderNot required
In-country Testing RequirementNo testing required

Talk to our Experts

Let us clarify how this news impacts you. Fill the form below and we will get back to you within 24 hours.

Gain comprehensive insights and the latest regulatory updates from around the globe with ORBIS Compliance's product certification management resources. Discover how to utilize these tools by completing our brief contact form for more information.